Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporterJian-Ge Qiu, Zhi Shi|Oncotarget|2015Cited by 67
Small-molecule agents for cancer immunotherapyFang Wang, Liwu Fu, Xue‐Ping Wang et al.|Acta Pharmaceutica Sinica B|2023Cited by 53
Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoproteinZhi Shi, Liwu Fu|Oncology Reports|2007Cited by 49
Targeting Snail1 by CRISPR/Cas9 System Inhibits the Proliferation and Migration of Human Gastric Cancer CellsPengwei Zhang, Zhi Shi|Journal of cancer research updates|2023Cited by 0
389P Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trialHan Li, Zhi Shi, Dongdong Zhou et al.|Annals of Oncology|2024Cited by 0